Rajender Vadija

Homology modeling and virtual screening of ubiquitin conjugation enzyme E2A for designing a novel selective antagonist against cancer

Vishwanath Ramatenki, Sarita Rajender Potlapally, Rama Krishna Dumpati et al. · Journal of Receptors and Signal Transduction · 2014 · 28 citations · Full text

Drug Target, Engineering, Novel Selective Antagonist +21

Homology modeling and virtual screening studies of FGF-7 protein—a structure-based approach to design new molecules against tumor angiogenesis

Rajender Vadija, Kiran Kumar Mustyala, Navaneetha Nambigari et al. · Journal of Chemical Biology · 2016 · 20 citations · Full text

Tumor Biology, Angiogenesis, Medicine +12

Structure-based drug design, synthesis and screening of MmaA1 inhibitors as novel anti-TB agents

Hymavathi Veeravarapu, Vasavi Malkhed, Kiran Kumar Mustyala et al. · Molecular Diversity · 2020 · 19 citations

Drug Target, Biochemistry, Medicine +9

Azolium analogues as CDK4 inhibitors: Pharmacophore modeling, 3D QSAR study and new lead drug discovery

Rohini Rondla, Lavanya Rao, Vishwanath Ramatenki et al. · Journal of Molecular Structure · 2017 · 17 citations

Medicinal Chemistry, Drug Target, Natural Sciences +11

Identification of New Lead Molecules Against UBE2NL Enzyme for Cancer Therapy

Vishwanath Ramatenki, Ramakrishna Dumpati, Rajender Vadija et al. · Applied Biochemistry and Biotechnology · 2017 · 14 citations

Cancer Therapy, Hit Identification, Biochemistry +6